According to our (Global Info Research) latest study, the global Animal-base Gelatin Haemostatic Sponge market size was valued at US$ 1183 million in 2025 and is forecast to a readjusted size of US$ 1536 million by 2032 with a CAGR of 4.1% during review period.
Animal-based gelatin haemostatic sponge is a sterile, absorbable topical haemostat manufactured from purified gelatin derived from animal collagen sources (most commonly porcine or bovine). The material is processed into a porous sponge matrix that can be cut or shaped and applied directly to a bleeding surface during surgery or dental procedures. When placed on a wound, the sponge rapidly absorbs blood and exudate, swells, and provides a mechanical scaffold that supports platelet adhesion and clot formation; it can also be used with topical thrombin to accelerate haemostasis in oozing or diffuse bleeding. Because the sponge is bioresorbable, it is designed to be left in situ when removal is impractical, then gradually degraded and absorbed by the body over time, depending on product design and local conditions. Selection and safe use depend on the surgical site, available space (since swelling can create pressure in confined areas), required size and thickness, and compliance with sterility and biocompatibility requirements. Prices for Animal-base Gelatin Haemostatic Sponges vary widely by brand tier, sponge format (sheet vs. dental cubes), sterility/pack configuration, and the procurement channel (hospital contract vs. retail). The gross profit margin of major companies in the industry is between 10% – 30%. Small dental cubes typically fall around $0.5–$2.0 per piece. Standard OR sheets/blocks are commonly $20–$40 per piece, while larger formats or premium branded packs can reach $80–$120 per piece. The gross profit margin of major companies in the industry is between 10% – 30%.
This report is a detailed and comprehensive analysis for global Animal-base Gelatin Haemostatic Sponge market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Animal-base Gelatin Haemostatic Sponge market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Animal-base Gelatin Haemostatic Sponge market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Animal-base Gelatin Haemostatic Sponge market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Animal-base Gelatin Haemostatic Sponge market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Animal-base Gelatin Haemostatic Sponge
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Animal-base Gelatin Haemostatic Sponge market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Johnson & Johnson, B. Braun, Gelita Medical, Cura Medical, Aegis Lifesciences, COLTENE, Dispotech, Ferrosan Medical Devices, EUCARE Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Animal-base Gelatin Haemostatic Sponge market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Porcine Gelatin Haemostatic Sponge
Cow Gelatin Haemostatic Sponge
Others
Market segment by Product Form
Sponge Sheets
Sponge Particles
Others
Market segment by Application
Hospitals
Clinics
Others
Major players covered
Pfizer
Johnson & Johnson
B. Braun
Gelita Medical
Cura Medical
Aegis Lifesciences
COLTENE
Dispotech
Ferrosan Medical Devices
EUCARE Pharmaceuticals
BOENMED
Medelast
JIAXING KENYUE
Medzeel Lifescience
Goodwill Lifesciences
Equimedical
Healthium Medtech
Septodont
Assut Europe
Nanchang Hushida Medical Technology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Animal-base Gelatin Haemostatic Sponge product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Animal-base Gelatin Haemostatic Sponge, with price, sales quantity, revenue, and global market share of Animal-base Gelatin Haemostatic Sponge from 2021 to 2026.
Chapter 3, the Animal-base Gelatin Haemostatic Sponge competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Animal-base Gelatin Haemostatic Sponge breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Animal-base Gelatin Haemostatic Sponge market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Animal-base Gelatin Haemostatic Sponge.
Chapter 14 and 15, to describe Animal-base Gelatin Haemostatic Sponge sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Animal-base Gelatin Haemostatic Sponge. Industry analysis & Market Report on Animal-base Gelatin Haemostatic Sponge is a syndicated market report, published as Global Animal-base Gelatin Haemostatic Sponge Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Animal-base Gelatin Haemostatic Sponge market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.